The Technical Analyst
Select Language :
Viridian Therapeutics, [VRDN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Viridian Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Viridian Therapeutics, is listed at the  Exchange

0.00% $17.51

America/New_York / 28 mar 2024 @ 16:00


Viridian Therapeutics,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 099.06 mill
EPS: -5.31
P/E: -3.30
Earnings Date: May 07, 2024
SharesOutstanding: 62.77 mill
Avg Daily Volume: 0.983 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/a
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.30 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.56x
Company: PE -3.30 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$1.790
(-89.78%) $-15.72
Date: 2024-03-29
Expected Trading Range (DAY)

$ 16.19 - 18.83

( +/- 7.56%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-12 Tousignant Jennifer Buy 0
2024-02-12 Tousignant Jennifer Buy 290 000 Stock Option (Right to Buy)
2024-02-05 Ciulla Thomas Buy 50 000 Stock Option (Right to Buy)
2024-01-22 Fairmount Funds Management Llc Buy 476 190 Common Stock
2024-01-03 Ciulla Thomas Sell 0 Common Stock
INSIDER POWER
59.35
Last 95 transactions
Buy: 5 615 027 | Sell: 1 533 788

Forecast: 16:00 - $17.49

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $17.49
Forecast 2: 16:00 - $17.49
Forecast 3: 16:00 - $17.49
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $17.51 (0.00% )
Volume 0.940 mill
Avg. Vol. 0.983 mill
% of Avg. Vol 95.68 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Viridian Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Viridian Therapeutics, Inc.

RSI

Intraday RSI14 chart for Viridian Therapeutics, Inc.

Last 10 Buy & Sell Signals For VRDN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$17.81N/AActive
Profile picture for
            Viridian Therapeutics, Inc.

VRDN

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Last 10 Buy Signals

Date Signal @
SWETHUSDMar 29 - 07:543 709.58
LTCUSDMar 29 - 07:55$102.40
PEPECOINUSDMar 29 - 07:545.90
NXMUSDMar 29 - 07:5072.32
GNSUSDMar 29 - 07:545.06
BGBUSDMar 29 - 07:541.005
BUSDUSDMar 29 - 07:541.001
ONTUSDMar 29 - 07:52$0.369
FOLDUSDMar 29 - 07:5026.93
CFXUSDMar 29 - 07:49$0.478

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.